Category: Joint ventures/collaborations
-
Sleeping Sickness Treatment Found in Cancer Drug
An experimental drug designed to treat solid tumor cancers was shown in lab tests to rid mice of human African trypanosomiasis, also known as sleeping sickness.
-
Heart Research Built Into Personalized Activity Tracker
An activity tracking device introduced earlier this year uses data from a major population health study to write its algorithms measuring exercise achievement to prevent heart disease.
-
Spacecraft Returns with Space Station Research Samples
A SpaceX Dragon spacecraft returned today with samples from several biomedical research studies conducted by astronauts on the International Space Station.
-
Lower-Risk Blood Thinning Drugs Designed
Researchers from academic and industry labs designed anti-coagulation treatments for people in danger of blood clots, but less likely to cause excessive bleeding than current drugs.
-
FDA Giving Fast-Track Review to Alzheimer’s Candidate
U.S. Food and Drug Administration is giving an accelerated review to a candidate drug designed to treat Alzheimer’s disease by reducing the toxicity of amyloid beta proteins making up the plaque accumulating in the brain.
-
Computer Models to Boost 3-D Print Designs in Mfring
An academic-industry team is developing computer-based methods to improve the design for three-dimensional printing of complex manufactured items.
-
Molecular Express, Baylor Medicine Partner on Vaccines
Vaccine developer Molecular Express and Baylor College of Medicine in Houston are developing boosters for vaccines from pieces of viruses that increase immune response to disease, including cancer.
-
Stanford, Google Partner on Genomic Health Analysis
Stanford University’s medical departments and Google’s cloud service are collaborating on a plan to make genomics a more routine part of health care.
-
Stem Cells Banked for Bipolar Disorder Research
Stem cells from people with bipolar disorder are being collected by an academic-industry partnership for scientists worldwide who study the disorder.
-
Amgen, Advaxis Partner on Personal Cancer Immunotherapy
Biological drug maker Amgen is licensing precision immunotherapy technology from Advaxis Inc. to develop treatments for cancer.